Endocannabinoid signaling regulates spontaneous transmitter release from embryonic retinal amacrine cells

Visual Neuroscience

Volumn 24, Issue 1, 2007, Pages 25-35

  Warrier, Ajithkumar ^a   Wilson, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amacrine cell; CB1R; Endocannabinoid; Retina; Spontaneous mini frequency

Indexed keywords

CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CYCLIC AMP; ENDOCANNABINOID; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; EMBRYO; IMMUNOCYTOCHEMISTRY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RETINA AMACRINE CELL; SIGNAL TRANSDUCTION; SYNAPSE;

AMACRINE CELLS; ANIMALS; CALCIUM; CELLS, CULTURED; CHICK EMBRYO; CYCLIC AMP; ELECTROPHYSIOLOGY; ENDOCANNABINOIDS; IMMUNOHISTOCHEMISTRY; PATCH-CLAMP TECHNIQUES; RECEPTOR, CANNABINOID, CB1; RETINA; SIGNAL TRANSDUCTION;

EID: 34247877740     PISSN: 09525238     EISSN: 14698714     Source Type: Journal    
DOI: 10.1017/S0952523807230160     Document Type: Article

References (66)

1. ALGER, B.E. (2002). Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoids. Progress In Neurobiology 68, 247-286.
2. BACCI, A., HUGUENARD, J.R. & PRINCE, D.A. (2004). Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431, 312-316.
3. BERNARD, C., MILH, M., MOROZOV, Y.M., BEN-ARI, Y., FREUND, T.F. & GOZLAN, H. (2005). Altering cannabinoid signaling during development disrupts neuronal activity. Proceedings of the National Academy of Science of the USA 102, 9388-9393.
4. BIEDA, M.C. & COPENHAGEN, D.R. (1999). Sodium action potentials are not required for light-evoked release of GABA or glycine from retinal amacrine cells. Journal of Neurophysiology 81, 3092-3095.
5. BOURON, A. (2001). Modulation of spontaneous quantal release of neurotransmitters in the hippocampus. Progressive Neurobiology 63, 613-635.
6. CHAN, P.K., CHAN, S.C. & YUNG, W.H. (1998). Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist. Neuroreport 9, 671-675.
7. DIANA, M.A., LEVENES, C., MACKIE, K. & MARTY, A. (2002). Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. Journal of Neuroscience 22, 200-208.
8. DIANA, M.A. & MARTY, A. (2004). Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). British Journal of Pharmacology 142, 9-19.
9. DING, L., PERKEL, D.J. & FARRIES, MA. (2003). Presynaptic depression of glutamatergic synaptic transmission by D1-like dopamine receptor activation in the avian basal ganglia. Journal of Neuroscience 23, 6086-6095.
10. EVANS, G.J. & MORGAN, A. (2003). Regulation of the exocytotic machinery by cAMP-dependent protein kinase: Implications for presynaptic plasticity. Biochemical Society Transactions 31, 824-827.
11. FAN, S.F. & YAZULLA, S. (2005). Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina. Visual Neuroscience 22, 55-63.
12. FATT, P. & KATZ, B. (1950). Some observations on biological noise. Nature 166, 597-598.
13. FEANY, M.B., LEE, S., EDWARDS, R.H. & BUCKLEY, K.M. (1992). The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70, 861-867.
14. FORTIN, D.A., TRETTEL, J. & LEVINE, E.S. (2004). Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. Journal of Neurophysiology 92, 2105-2112.
15. FRECH, M.J., PEREZ-LEON, J., WASSLE, H. & BACKUS, K.H. (2001). Characterization of the spontaneous synaptic activity of amacrine cells in the mouse retina. Journal of Neurophysiology 86, 1632-1643.
16. FRERKING, M., BORGES, S. & WILSON, M. (1995). Variation in GABA mini amplitude is the consequence of variation in transmitter concentration. Neuron 15, 885-895.
17. FRERKING, M., BORGES, S. & WILSON, M. (1997). Are some minis multi-quantal? Journal of Neurophysiology 78, 1293-1304.
18. FREUND, T.F. (2003). Interneuron Diversity series: Rhythm and mood in perisomatic inhibition. Trends in Neuroscience 26, 489-495.
19. GLEASON, E., BORGES, S. & WILSON, M. (1993). Synaptic transmission between pairs of retinal amacrine cells in culture. Journal of Neuroscience 13, 2359-2370.
20. GLEASON, E., BORGES, S. & WILSON, M. (1994). Control of transmitter release from retinal amacrine cells by Ca2+ influx and efflux. Neuron 13, 1109-1117.
21. GLEASON, E. & WILSON, M. (1989). Development of synapses between chick retinal neurons in dispersed culture. The Journal of Comparative Neurology 287, 213-224.
22. GREEN, K., KIM, K. & BOWMAN, K. (1976). Ocular effects of delta(9)-tetrahydrocannabinol. In The Therapeutic Aspects of Marihuana, ed. Stillman, R., pp. 49-62. New York: Plenum Press.
23. HAJOS, N. & FREUND, T.F. (2002a). Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chemistry and Physics of Lipids 121, 73-82.
24. HAJOS, N. & FREUND, T.F. (2002b). Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43, 503-510.
25. HAJOS, N., LEDENT, C. & FREUND, T.F. (2001). Novel cannabinoidsensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106, 1-4.
26. HILLARD, C.J. (2000). Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins & Other Lipid Mediators 61, 3-18.
27. HILLARD, C.J., MANNA, S., GREENBERG, M.J., DICAMELLI, R., ROSS, R.A., STEVENSON, L.A., MURPHY, V., PERTWEE, R.G. & CAMPBELL, W.B. (1999). Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). The Journal of Pharmacology and Experimental Therapeutics 289, 1427-1433.
28. HOFFMAN, A.F. & LUPICA, C.R. (2000). Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. Journal of Neuroscience 20, 2470-2479.
29. HOFFMAN, A.F., MACGILL, A.M., SMITH, D., OZ, M. & LUPICA, C.R. (2005). Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. European Journal of Neuroscience 22, 2387-2391.
30. HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE,W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacology Review 54, 161-202.
31. HOWLETT, A.C., BREIVOGEL, C.S., CHILDERS, S.R., DEADWYLER, S.A., HAMPSON, R.E. & PORRINO, L.J. (2004). Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 Suppl 1, 345-358.
32. HOWLETT, A.C. & MUKHOPADHYAY, S. (2000). Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chemistry and Physics of Lipids 108, 53-70.
33. HURTADO, J., BORGES, S. & WILSON, M. (2002). Na(+)-Ca(2+) exchanger controls the gain of the Ca(2+) amplifier in the dendrites of amacrine cells. Journal of Neurophysiology 88, 2765-2777.
34. KANEKO, M. & TAKAHASHI, T. (2004). Presynaptic mechanism underlying cAMP-dependent synaptic potentiation. Journal of Neuroscience 24, 5202-5208.
35. KREITZER, A.C. & REGEHR, W.G. (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29, 717-727.
36. LUKASIEWICZ, P.D. (2005). Synaptic mechanisms that shape visual signaling at the inner retina. Progress in Brain Research 147, 205-218.
37. MARC, R.E. & LIU, W. (2000). Fundamental GABAergic amacrine cell circuitries in the retina: Nested feedback, concatenated inhibition, and axosomatic synapses. Journal of Comparative Neurology 425, 560-582.
38. MARCAGGI, P. & ATTWELL, D. (2005). Endocannabinoid signaling depends on the spatial pattern of synapse activation. Nature Neuroscience 8, 776-781.
39. MARINELLI, S., DI MARZO, V., BERRETTA, N., MATIAS, I., MACCARRONE, M., BERNARDI, G. & MERCURI, N. B. (2003). Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. Journal of Neuroscience 23, 3136-3144.
40. MARINELLI, S., PASCUCCI, T., BERNARDI, G., PUGLISI-ALLEGRA, S. & MERCURI, N.B. (2005). Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 30, 864-870.
41. MARINELLI, S., VAUGHAN, C.W., CHRISTIE, M.J. & CONNOR, M. (2002). Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. Journal of Physiology 543, 531-540.
42. MARKRAM, H., TOLEDO-RODRIGUEZ, M., WANG, Y., GUPTA, A., SILBERBERG, G. & WU, C. (2004). Interneurons of the neocortical inhibitory system. Nature Reviews Neuroscience 5, 793-807.
43. MARSICANO, G., WOTJAK, C.T., AZAD, S. C., BISOGNO, T., RAMMES, G., CASCIO, M.G., HERMANN, H., TANG, J., HOFMANN, C., ZIEGLGANSBERGER, W., DI MARZO, V. & LUTZ, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530-534.
44. MELIS, M., PISTIS, M., PERRA, S., MUNTONI, A.L., PILLOLLA, G. & GESSA, G.L. (2004). Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. Journal of Neuroscience 24, 53-62.
45. PERTWEE, R.G. (2005). Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sciences 76, 1307-1324.
46. PIOMELLI, D. (2003). The molecular logic of endocannabinoid signalling. Nature Reviews Neuroscience 4, 873-884.
47. PRANGE, O. & MURPHY, T.H. (1999). Correlation of miniature synaptic activity and evoked release probability in cultures of cortical neurons. Journal of Neuroscience 19, 6427-6438.
48. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D. & ET AL. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters 350, 240-244.
49. RINALDI-CARMONA, M., PIALOT, F., CONGY, C., REDON, E., BARTH, F., BACHY, A., BRELIERE, J.C., SOUBRIE, P. & LE FUR, G. (1996). Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sciences 58, 1239-1247.
50. RONESI, J., GERDEMAN, G.L. & LOVINGER, D.M. (2004). Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. Journal of Neuroscience 24, 1673-1679.
51. SAKABA, T. & NEHER, E. (2001). Preferential potentiation of fast-releasing synaptic vesicles by cAMP at the calyx of Held. Proceedings of the National Academy of Sciences of the USA 98, 331-336.
52. SAKABA, T. & NEHER, E. (2003). Direct modulation of synaptic vesicle priming by GABA(B) receptor activation at a glutamatergic synapse. Nature 424, 775-778.
53. STRAIKER, A., STELLA, N., PIOMELLI, D., MACKIE, K., KARTEN, H.J. & MAGUIRE, G. (1999). Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system. Proceedings of the National Academy of Sciences of the USA 96, 14565-14570.
54. STRAIKER, A. & SULLIVAN, J.M. (2003). Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. Journal of Neurophysiology 89, 2647-2654.
55. SULLIVAN, J.M. (1999). Mechanisms of cannabinoid-receptor- mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. Journal of Neurophysiology 82, 1286-1294.
56. TAKAHASHI, K.A. & LINDEN, D.J. (2000). Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. Journal of Neurophysiology 83, 1167-1180.
57. TURRIGIANO, G.G. & NELSON, S.B. (2004). Homeostatic plasticity in the developing nervous system. Nature Reviews Neuroscience 5, 97-107.
58. VAN DER STELT, M. & DI MARZO, V. (2004). Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. European Journal of Biochemistry 271, 1827-1834.
59. VIGH, J. & LASATER, E.M. (2004). L-type calcium channels mediate transmitter release in isolated, wide-field retinal amacrine cells. Visual Neuroscience 21, 129-134.
60. WARRIER, A., BORGES, S., DALCINO, D., WALTERS, C. & WILSON, M. (2005). Calcium from internal stores triggers GABA release from retinal amacrine cells. Journal of Neurophysiology 94, 4196-4208.
61. WATANABE, S., KOIZUMI, A., MATSUNAGA, S., STOCKER, J.W. & KANEKO, A. (2000). GABA-Mediated inhibition between amacrine cells in the goldfish retina. Journal of Neurophysiology 84, 1826-1834.
62. WILEY, J.L. & MARTIN, B.R. (2002). Cannabinoid pharmacology: Implications for additional cannabinoid receptor subtypes. Chemistry and Physics of Lipids 121, 57-63.
63. WILSON, R.I. & NICOLL, R.A. (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
64. YAZULLA, S. & STUDHOLME, K.M. (2004). Vanilloid receptor like 1 (VRL1) immunoreactivity in mammalian retina: colocalization with somatostatin and purinergic P2X1 receptors. Journal of Comparative Neurology 474, 407-418.
65. YAZULLA, S., STUDHOLME, K.M., MCI NTOSH, H.H. & DEUTSCH, D.G. (1999). Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. Journal of Comparative Neurology 415, 80-90.
66. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452-457.